Augurex Announces Expansion of Availability of the JOINTstat Diagnostic Test for Rheumatoid Arthritis with MitogenDx
News Source : Financial Post
News Summary
- Augurex Life Sciences Corp., a leader in autoimmune-based diagnostics, today announced an agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic testing.
- Under this agreement, Mitogendx will offer the JOINTstat® blood test, expanding access to advanced r heumatoid arthritis (RA) diagnostic testing and disease monitoring for clinicians and patients across Canada.JOINTstat is a Health Canada Class II in vitro diagnostic blood test that detects 14-3-3eta, a biomarker approved for diagnosing and monitoring RA.
Augurex has partnered with MitogenDx to expand access to JOINTstat testing across Canada, improving physician and patient access to advanced tools for rheumatoid arthritis (RA) diagnosis and [+6816 chars]